Tool targets cancer-causing fusions’ weak spot

by

Scientists at St. Jude Children’s Research Hospital comprehensively characterized oncogenic fusions in pediatric cancer, providing proof-of-principle for genetic engineering-based therapies.

Leave A Comment

Your email address will not be published. Required fields are marked *